221 related articles for article (PubMed ID: 37519801)
1. Radiomics features of computed tomography and magnetic resonance imaging for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis.
Feng L; Chen Q; Huang L; Long L
Front Oncol; 2023; 13():1194200. PubMed ID: 37519801
[TBL] [Abstract][Full Text] [Related]
2. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract][Full Text] [Related]
3. Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma.
Zhao Y; Wang N; Wu J; Zhang Q; Lin T; Yao Y; Chen Z; Wang M; Sheng L; Liu J; Song Q; Wang F; An X; Guo Y; Li X; Wu T; Liu AL
Front Oncol; 2021; 11():582788. PubMed ID: 33868988
[TBL] [Abstract][Full Text] [Related]
4. Application of Radiomics in the Efficacy Evaluation of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Wang Y; Li M; Zhang Z; Gao M; Zhao L
Acad Radiol; 2024 Jan; 31(1):273-285. PubMed ID: 37684182
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Efficacy of Contrast-Enhanced MRI in Detecting Residual or Recurrent Hepatocellular Carcinoma After Transarterial Chemoembolization: A Systematic Review and Meta-analysis.
Liu HF; Zou LQ; Lu XR; Sheng Y; Wang Q; Ding JL; Shi L; Liu SQ; Xing W
J Magn Reson Imaging; 2020 Oct; 52(4):1019-1028. PubMed ID: 31675170
[TBL] [Abstract][Full Text] [Related]
6. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
Kim J; Choi SJ; Lee SH; Lee HY; Park H
AJR Am J Roentgenol; 2018 Nov; 211(5):1026-1034. PubMed ID: 30240304
[TBL] [Abstract][Full Text] [Related]
7. Preoperative CECT-based Radiomic Signature for Predicting the Response of Transarterial Chemoembolization (TACE) Therapy in Hepatocellular Carcinoma.
Bai H; Meng S; Xiong C; Liu Z; Shi W; Ren Q; Xia W; Zhao X; Jian J; Song Y; Ni C; Gao X; Li Z
Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1524-1533. PubMed ID: 35896687
[TBL] [Abstract][Full Text] [Related]
8. Radiomics for Predicting Response of Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.
Yang C; Jiang Z; Cheng T; Zhou R; Wang G; Jing D; Bo L; Huang P; Wang J; Zhang D; Jiang J; Wang X; Lu H; Zhang Z; Li D
Front Oncol; 2022; 12():893103. PubMed ID: 35600395
[TBL] [Abstract][Full Text] [Related]
9. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel combined nomogram model integrating Rad-score, age and ECOG to predict the survival of patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
Liu A; Liu B; Duan X; Yang B; Wang Y; Dong P; Zhou P
J Gastrointest Oncol; 2022 Aug; 13(4):1889-1897. PubMed ID: 36092317
[TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence with magnetic resonance imaging for prediction of pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis.
Jia LL; Zheng QY; Tian JH; He DL; Zhao JX; Zhao LP; Huang G
Front Oncol; 2022; 12():1026216. PubMed ID: 36313696
[TBL] [Abstract][Full Text] [Related]
12. Radiomics models for preoperative prediction of microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis.
Zhong X; Long H; Su L; Zheng R; Wang W; Duan Y; Hu H; Lin M; Xie X
Abdom Radiol (NY); 2022 Jun; 47(6):2071-2088. PubMed ID: 35364684
[TBL] [Abstract][Full Text] [Related]
13. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
[No Abstract] [Full Text] [Related]
14. Preoperative prediction power of radiomics and non-radiomics methods based on MRI for early recurrence in hepatocellular carcinoma: a systemic review and meta-analysis.
Lu M; Wang C; Zhuo Y; Gou J; Li Y; Li J; Dong X
Abdom Radiol (NY); 2024 May; ():. PubMed ID: 38704783
[TBL] [Abstract][Full Text] [Related]
15. Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Meng XP; Wang YC; Ju S; Lu CQ; Zhong BY; Ni CF; Zhang Q; Yu Q; Xu J; Ji J; Zhang XM; Tang TY; Yang G; Zhao Z
Front Oncol; 2020; 10():1196. PubMed ID: 32850345
[TBL] [Abstract][Full Text] [Related]
16. Radiomics analysis of pretreatment MRI in predicting tumor response and outcome in hepatocellular carcinoma with transarterial chemoembolization: a two-center collaborative study.
Liu QP; Yang KL; Xu X; Liu XS; Qu JR; Zhang YD
Abdom Radiol (NY); 2022 Feb; 47(2):651-663. PubMed ID: 34918174
[TBL] [Abstract][Full Text] [Related]
17. Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound.
Liu D; Liu F; Xie X; Su L; Liu M; Xie X; Kuang M; Huang G; Wang Y; Zhou H; Wang K; Lin M; Tian J
Eur Radiol; 2020 Apr; 30(4):2365-2376. PubMed ID: 31900703
[TBL] [Abstract][Full Text] [Related]
18. Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning.
Peng J; Huang J; Huang G; Zhang J
Front Oncol; 2021; 11():730282. PubMed ID: 34745952
[TBL] [Abstract][Full Text] [Related]
19. CT-based radiomics for predicting Ki-67 expression in lung cancer: a systematic review and meta-analysis.
Luo X; Zheng R; Zhang J; He J; Luo W; Jiang Z; Li Q
Front Oncol; 2024; 14():1329801. PubMed ID: 38384802
[TBL] [Abstract][Full Text] [Related]
20. Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: A systematic review and meta‑analysis.
Jia LL; Zhao JX; Zhao LP; Tian JH; Huang G
Eur J Radiol; 2023 Jan; 158():110640. PubMed ID: 36525703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
